Shu-Chih Chen
Founder chez ATOSSA THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Shu-Chih Chen is the founder and director at Atossa Therapeutics, Inc., which was founded in 2008.
She was also the founder and former president of SC2Q Consulting Co., which was founded in 2006.
Dr. Chen's former job includes being the head of cell biology at MDRNA, Inc. from 2002 to 2006.
She was also an associate professor at National Yang Ming University and the president of Ensisheim Partners LLC.
Dr. Chen holds a doctorate degree from Michigan State University, which she received in 1992, and an undergraduate degree from National Yang Ming University, which she received in 1984.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Shu-Chih Chen
| Sociétés | Poste | Début |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Founder | 01/12/2008 |
Anciens postes connus de Shu-Chih Chen
| Sociétés | Poste | Fin |
|---|---|---|
| SC2Q Consulting Co. | Founder | 01/01/2008 |
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Director/Board Member | 01/01/2006 |
| Ensisheim Partners LLC | President | - |
| National Yang Ming University | Corporate Officer/Principal | - |
Formation de Shu-Chih Chen
| Michigan State University | Doctorate Degree |
| National Yang Ming University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
| SC2Q Consulting Co. | |
| Ensisheim Partners LLC |
